The global pharmaceutical industry experienced a 15% decline in the number of microbiome-related patent applications in Q1 2024 compared with the previous quarter. The total number of microbiome-related grants dropped by 11% in Q1 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook Pharma: Patents Trends Q1 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Pharma: Patents Trends Q1 2024

Buy the Databook

Premium Insights

The gold standard of business intelligence.

Find out more

Notably, the number of microbiome-related patent applications in the pharmaceutical industry was 211 in Q1 2024, versus 249 in the prior quarter.

The top five companies accounted for 12% of patenting activity

Analysis of patenting activity by companies shows that Kookmin University Cooperative filed the most microbiome patents within the pharmaceutical industry in Q1 2024. The company filed 6 microbiome-related patents in the quarter, compared with 3 in the previous quarter. It was followed by Eurobio Scientific with 6 microbiome patent filings, AOBiome (5 filings), and Seed Health (5 filings) in Q1 2024.

Patenting activity was driven by the US with a 40% share of total patent filings

The largest share of microbiome related patent filings in the pharmaceutical industry in Q1 2024 was in the US with 40%, followed by Australia (6%) and China (6%). The share represented by the US was 3% lower than the 43% share it accounted for in Q4 2023.

For further understanding of GlobalData's Pharma: Patents Trends Q1 2024, buy the databook here.

This content was updated on 18 April 2024

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.